Lieuwe D J Bos,Michael Sjoding,Pratik Sinha,Sivasubramanium V Bhavani,Patrick G Lyons,Alice F Bewley,Michela Botta,Anissa M Tsonas,Ary Serpa Neto,Marcus J Schultz,Robert P Dickson,Frederique Paulus,PRoVENT-COVID collaborative group,J P van Akkeren,A G Algera,C K Algoe,R B van Amstel,A Artigas,O L Baur,P van de Berg,A E van den Berg,D C J J Bergmans,D I van den Bersselaar,F A Bertens,A J G H Bindels,M M de Boer,S den Boer,L S Boers,M Bogerd,L D J Bos,M Botta,J S Breel,H de Bruin,S de Bruin,C L Bruna,L A Buiteman-Kruizinga,O Cremer,R M Determann,W Dieperink,D A Dongelmans,H S Franke,M S Galek-Aldridge,M J de Graaff,L A Hagens,J J Haringman,S T van der Heide,P L J van der Heiden,N F L Heijnen,S J P Hiel,L L Hoeijmakers,L Hol,M W Hollmann,M E Hoogendoorn,J Horn,R van der Horst,E L K Ie,D Ivanov,N P Juffermans,E Kho,E S de Klerk,A W M M Koopman-van Gemert,M Koopmans,S Kucukcelebi,M A Kuiper,D W de Lange,I Martin-Loeches,G Mazzinari,D M P van Meenen,L Morales-Quinteros,N van Mourik,S G Nijbroek,M Onrust,E A N Oostdijk,F Paulus,C J Pennartz,J Pillay,L Pisani,I M Purmer,T C D Rettig,J P Roozeman,M T U Schuijt,M J Schultz,A Serpa Neto,M E Sleeswijk,M R Smit,P E Spronk,W Stilma,A C Strang,A M Tsonas,P R Tuinman,C M A Valk,F L Veen-Schra,L I Veldhuis,P van Velzen,W H van der Ven,A P J Vlaar,P van Vliet,P H J van der Voort,L van Welie,H J F T Wesselink,H H van der Wier-Lubbers,B van Wijk,T Winters,W Y Wong,A R H van Zanten

Abstract:Background: Patients with COVID-19-related acute respiratory distress syndrome (ARDS) have been postulated to present with distinct respiratory subphenotypes. However, most phenotyping schema have been limited by sample size, disregard for temporal dynamics, and insufficient validation. We aimed to identify respiratory subphenotypes of COVID-19-related ARDS using unbiased data-driven approaches. Methods: PRoVENT-COVID was an investigator-initiated, national, multicentre, prospective, observational cohort study at 22 intensive care units (ICUs) in the Netherlands. Consecutive patients who had received invasive mechanical ventilation for COVID-19 (aged 18 years or older) served as the derivation cohort, and similar patients from two ICUs in the USA served as the replication cohorts. COVID-19 was confirmed by positive RT-PCR. We used latent class analysis to identify subphenotypes using clinically available respiratory data cross-sectionally at baseline, and longitudinally using 8-hourly data from the first 4 days of invasive ventilation. We used group-based trajectory modelling to evaluate trajectories of individual variables and to facilitate potential clinical translation. The PRoVENT-COVID study is registered with ClinicalTrials.gov, NCT04346342. Findings: Between March 1, 2020, and May 15, 2020, 1007 patients were admitted to participating ICUs in the Netherlands, and included in the derivation cohort. Data for 288 patients were included in replication cohort 1 and 326 in replication cohort 2. Cross-sectional latent class analysis did not identify any underlying subphenotypes. Longitudinal latent class analysis identified two distinct subphenotypes. Subphenotype 2 was characterised by higher mechanical power, minute ventilation, and ventilatory ratio over the first 4 days of invasive mechanical ventilation than subphenotype 1, but PaO2/FiO2, pH, and compliance of the respiratory system did not differ between the two subphenotypes. 185 (28%) of 671 patients with subphenotype 1 and 109 (32%) of 336 patients with subphenotype 2 had died at day 28 (p=0·10). However, patients with subphenotype 2 had fewer ventilator-free days at day 28 (median 0, IQR 0-15 vs 5, 0-17; p=0·016) and more frequent venous thrombotic events (109 [32%] of 336 patients vs 176 [26%] of 671 patients; p=0·048) compared with subphenotype 1. Group-based trajectory modelling revealed trajectories of ventilatory ratio and mechanical power with similar dynamics to those observed in latent class analysis-derived trajectory subphenotypes. The two trajectories were: a stable value for ventilatory ratio or mechanical power over the first 4 days of invasive mechanical ventilation (trajectory A) or an upward trajectory (trajectory B). However, upward trajectories were better independent prognosticators for 28-day mortality (OR 1·64, 95% CI 1·17-2·29 for ventilatory ratio; 1·82, 1·24-2·66 for mechanical power). The association between upward ventilatory ratio trajectories (trajectory B) and 28-day mortality was confirmed in the replication cohorts (OR 4·65, 95% CI 1·87-11·6 for ventilatory ratio in replication cohort 1; 1·89, 1·05-3·37 for ventilatory ratio in replication cohort 2). Interpretation: At baseline, COVID-19-related ARDS has no consistent respiratory subphenotype. Patients diverged from a fairly homogenous to a more heterogeneous population, with trajectories of ventilatory ratio and mechanical power being the most discriminatory. Modelling these parameters alone provided prognostic value for duration of mechanical ventilation and mortality. Funding: Amsterdam UMC.

Novel subtypes of severe COVID-19 respiratory failure based on biological heterogeneity: a secondary analysis of a randomized controlled trial

Latent Class Analysis Reveals COVID-19–related Acute Respiratory Distress Syndrome Subgroups with Differential Responses to Corticosteroids

Inflammatory sub-phenotypes in sepsis: relationship to outcomes, treatment effect and transcriptomic sub-phenotypes

Unraveling SARS-CoV-2 Host-Response Heterogeneity through Longitudinal Molecular Subtyping

Trajectories of Host-Response Subphenotypes in Patients With COVID-19 Across the Spectrum of Respiratory Support

Identification of Three Classes of Acute Respiratory Distress Syndrome Using Latent Class Analysis

Clinical severity classes in COVID-19 pneumonia have distinct immunological profiles, facilitating risk stratification by machine learning

Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis

Patient stratification using plasma cytokines and their regulators in sepsis: relationship to outcomes, treatment effect and leucocyte transcriptomic subphenotypes

Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study

Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease

Longitudinal respiratory subphenotypes in patients with COVID-19-related acute respiratory distress syndrome: results from three observational cohorts

Molecular states during acute COVID-19 reveal distinct etiologies of long-term sequelae

SARS-CoV-2 Infection Triggers Profibrotic Macrophage Responses and Lung Fibrosis

Heterogeneity of treatment effect of vilobelimab in COVID-19: a secondary analysis of a randomised controlled trial

Using a targeted metabolomics approach to explore differences in ARDS associated with COVID-19 compared to ARDS caused by H1N1 influenza and bacterial pneumonia

Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials

Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials

Integrated longitudinal multiomics study identifies immune programs associated with acute COVID-19 severity and mortality

Delineating COVID-19 subgroups using routine clinical data identifies distinct in-hospital outcomes

International multi-cohort analysis identifies novel framework for quantifying immune dysregulation in critical illness: results of the SUBSPACE consortium